Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04204837
Title Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Salzburger Landeskliniken
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUT


No variant requirements are available.